Docket Nexus — Federal court records.
Patent - ANDA Lawsuit

Amgen Inc v. The Acme Laboratories Ltd

Patent - ANDA Terminated 11/20/2019 District Court, D. Delaware

Amgen Inc v. The Acme Laboratories Ltd is a federal patent - anda lawsuit filed on 09/11/2019 in the District Court, D. Delaware. The case was terminated on 11/20/2019.

Court
District Court, D. Delaware (D. Del.)
Official Court Website →
Assigned judge
Mitchell S. Goldberg · 282 cases in index
Docket number
1:19-cv-01702
Cause
35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement
Nature of suit
835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.
Jurisdiction
Federal Question
Jury demand
None
Date filed
09/11/2019
Date terminated
11/20/2019

1,113 Patent - ANDA cases in this court are indexed here.

Parties

Part of a Larger Litigation Pattern

This is one of 2 Patent - ANDA cases in our index naming The ACME Laboratories Ltd — a possible mass-tort or coordinated-litigation cluster.

    About Patent - ANDA Lawsuits

    ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

    Frequently Asked Questions

    What is Amgen Inc v. The Acme Laboratories Ltd?

    Amgen Inc v. The Acme Laboratories Ltd is a federal patent - anda lawsuit filed on 09/11/2019 in the District Court, D. Delaware. The case was terminated on 11/20/2019. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

    What type of case is this?

    It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

    What court is the case in?

    The case is in the District Court, D. Delaware, docket number 1:19-cv-01702.

    When was the case filed?

    Amgen Inc v. The Acme Laboratories Ltd was filed on 09/11/2019. It was terminated on 11/20/2019.

    What law is the case brought under?

    The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.

    Other Cases Involving These Parties

    Related Patent - ANDA Cases

    Source: public U.S. federal court record (docket 16186200).